Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn more about the safety and dosing of rifampin in infants.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT06306014 · Clostridioides Difficile Infection, Recurrent Infection
NCT07183592 · Intensive Care (ICU), Central Venous Catheter Related Infections, and more
NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection
NCT07388173 · Respiratory Infections in Old Age
NCT05190978 · Breast Cancer, Breast Implant; Complications, Infection or Inflammation
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions